PUBLISHER: DataM Intelligence | PRODUCT CODE: 1643894
PUBLISHER: DataM Intelligence | PRODUCT CODE: 1643894
The global cuffless blood pressure monitoring devices market reached US$ 681.17 million in 2024 and is expected to reach US$ 1731.5 million by 2033, growing at a CAGR of 10.7% during the forecast period 2025-2033.
Cuffless blood pressure monitors are a diverse group of devices with various uses, but they face specific accuracy issues, making established validation protocols inadequate. Validation should address individual cuff calibration, measurement stability, BP change tracking, and machine learning implementation. Clinical field investigations may also be considered to address clinical implementation issues of cuffless BP readings.
Market Dynamics: Drivers & Restraints
Increasing Technological Advancements
The ongoing advancements in sensor technology, artificial intelligence, and machine learning are leading to the development of accurate, non-invasive cuffless blood pressure monitors. With the integration of IoT technologies, remote monitoring and telemedicine applications are further enhanced. Miniaturization and multi-functionality will enable these devices to be embedded in wearable products such as smartwatches and fitness trackers. These developments make users more comfortable with the device and increase compliance, introducing them into the daily routine in chronic disease management and preventive health care and subsequently causing market growth.
For instance, in November 2024, CART BP is the first-ever cuffless ring-shaped device in the world designed for continuous blood pressure monitoring, patented by a health tech startup in South Korea, Sky Labs. Unlike ordinary wrist-based smart watches, CART BP provides more stable signals from photoplethysmography (PPG) to offer an accurate reading of blood flow through the finger. Wrist-distributed devices typically suffer from poor accuracy, considering differences in wrist sizes and mechanical misalignment of sensors.
Hence, this innovation sets a new benchmark in the market, driving demand for more reliable and user-friendly monitoring solutions which is one of the factor of advancements that helps the market to grow during the forecast period.
Regulatory Challenges
The global cuffless blood pressure monitoring devices market is hindered by regulatory challenges. The approval process for medical devices varies across regions, creating a complex landscape for manufacturers to navigate. This lack of uniform global standards can lead to delays in product development, increased costs, and time-to-market for new sensors. Changes or inconsistencies in regulatory policies can also disrupt the market, making it difficult for manufacturers to maintain consistent product offerings. As a result, the introduction of Cuffless Blood Pressure Monitoring Devices slows overall industry growth.
The global cuffless blood pressure monitoring devices market is segmented based on product type, technology, application, end user and region.
Wrist-based segment is expected to dominate the Cuffless Blood Pressure Monitoring Devices market share
The wrist-based segment holds a major portion of the cuffless blood pressure monitoring devices market share and is expected to continue to hold a significant portion of the cuffless blood pressure monitoring devices market share during the forecast period.
Cuffless blood pressure monitoring is one domain, in which wrist-based devices find their highest contribution in the global marketing space, making themselves all so convenient and portable that they can be integrated with wearable technologies. These devices also possess the advantage of neither storage nor continuous blood pressure monitoring, making them quite appealing to medical and consumer needs. The evolution that smartwatches have made from newly introduced fitness trackers with blood pressure sensors can act as factors that drive the advancement powered by the various improvements made in optical and piezoelectric sensing technologies. The other driving factors in the market would be the product launches, increasing demand for multipurpose wearables, unifying health monitoring with lifestyle features and other various factors.
For instance, in August 2023, Corsano Health announced that it has successfully integrated cuffless blood pressure measurements into its new generation smart bracelet. cardiowatch 287-2 is a wireless and remote patient monitoring solution that collects continuous physiological data from the home and health facility, including heart rate, heart rate variability (R-R interval), respiration rate, activity, sleep, ECG, SpO2, body temperature, and blood pressure.
End User:-
Hospitals segment is the fastest-growing segment in Cuffless Blood Pressure Monitoring Devices market share
The hospitals segment is the fastest-growing segment in the cuffless blood pressure monitoring devices market share and is expected to hold the market share over the forecast period.
Hospitals are sure catalyzers for the growth of the global cuffless blood pressure monitoring device markets, making available possibilities for continuous, non-invasive blood pressure monitoring. Such devices further enhance patient comfort during long-term or post-surgical recovery because they provide automated blood pressure recording and data capture on an on-going basis. Data transmission in real-time allows the identification of blood pressure deviations earlier enough to permit intervention by a healthcare provider. Incorporating cuffless devices into EHR systems boosts workflow efficiency and improves personalized patient care.
As more hospitals adopt telemedicine solutions, cuffless blood pressure monitors will be essential for remote patient monitoring programs to have care continuity and decrease readmission numbers. The segment is consequently critical for clinically competent and technologically advanced solutions.
North America is expected to hold a significant position in the Cuffless Blood Pressure Monitoring Devices market share
North America holds a substantial position in the cuffless blood pressure monitoring devices market and is expected to hold most of the market share due to product launches, FDA clearance, advanced healthcare infrastructure and high healthcare expenditure. The rising prevalence of hypertension and cardiovascular diseases, coupled with an aging population, drives demand for innovative solutions. Technological advancements in wearable devices, telemedicine adoption, and home healthcare are key drivers. Strong regulatory frameworks, such as FDA approvals for cuffless devices, and growing consumer awareness about preventive health and wellness fuel market expansion in North America.
For instance, in January 2024, Nanowear is announced to be a front-runner in remote diagnostics for bringing health care home when it announced that its "nanotechnology-enabled wearable and software platform - SimpleSense has received FDA 510(k) clearance for a novel AI-enabled Software-as-a-MedicalDevice (SaMD). As the first non-invasive, cuffless continuous blood pressure monitor and diagnostics, SimpleSense BP is transforming a clinical diagnostic tool in the diagnostic management of hypertension and adds to the cardiopulmonary diagnostics previously cleared for the wearable platform.
Moreover, according to National Center for Health Statistics, in U.S Hypertension prevalence increases with age, with 23.4% in adults aged 18-39, 52.5% for 40-59, and 71.6% for 60 and older. Both men and women show a similar pattern, with higher prevalence in men aged 18-39 (30.0% compared to 16.4%) and 55.9% for 40-59, but not significantly different between men and women aged 60 and older.
Europe is growing at the fastest pace in the Cuffless Blood Pressure Monitoring Devices market
Europe holds the fastest pace in the cuffless blood pressure monitoring devices market and is expected to hold most of the market share due to growing focus on preventive healthcare and chronic disease management. The aging population and rising hypertension incidence drive demand for user-friendly monitoring solutions. Government initiatives, stringent regulatory standards, and collaborations between medical device companies and academic institutions contribute to growth. The integration of these devices into hospital systems and consumer wearables accelerates adoption across the region.
For instance, National Health Service, High blood pressure or hypertension is common among adults across the UK, at about one in three. In England, 31% of men have this condition, compared to 26% of women and up to six million across the UK, as described by Blood Pressure UK.
Hence, the high prevalence of hypertension among adults in the UK further demonstrates the importance of convening and accessible blood pressure monitoring technologies. Cuffless blood pressure monitoring devices facilitate continuous, non-invasive tracking of blood pressure for the convenience of users in self-managing their health. This development will contribute to market growth in line with the increasing emphasis by the UK on preventive healthcare and awareness campaigns for hypertension.
The major global players in the cuffless blood pressure monitoring devices market include Biobeat Technologies, Omron, CardiacSense, Valencell, Inc, Aktiia SA, Equate Health, Healthstats International Pte. Ltd., Corsano Health, SOMNOmedics AG, LiveMetric and among others.
The global cuffless blood pressure monitoring devices market report delivers a detailed analysis with 68+ key tables, more than 80 visually impactful figures, and 246 pages of expert insights, providing a complete view of the market landscape.
Target Audience 2024
Key Market Players
Emerging Market Players
LIST NOT EXHAUSTIVE